Lesson focus: Stimulant laxatives increase colonic motility and intestinal secretion. They are valuable short-term medicines and are often needed in opioid-related constipation, but they are not a substitute for diagnosing obstruction, impaction, bleeding or a new serious bowel disorder.
Learning objectives
Classify stimulant laxatives; explain their colonic effects; compare senna, bisacodyl, sodium picosulfate and castor oil; prescribe by indication and route; prevent enteric-coating errors; identify red flags/contraindications; and counsel patients about safe short-term use.
1. Before using a stimulant laxative
Constipation is a symptom. Ask about duration, stool form, flatus, vomiting, pain, bleeding, weight loss, diet, mobility, medicines and previous bowel disease. Check for faecal impaction and reversible medicine causes, especially opioids, anticholinergics, iron and calcium.
Do not give a stimulant laxative for suspected bowel obstruction or acute abdomen. Colicky abdominal pain with distension, vomiting, inability to pass stool/flatus, peritonism, haematemesis/melaena, rectal bleeding, fever, significant dehydration or sudden persistent change in bowel habit needs clinical assessment.
2. What are stimulant laxatives?
Stimulant laxatives act primarily in the colon by stimulating mucosal/enteric nerves and increasing secretion of water and electrolytes into the lumen. The result is increased propulsive peristalsis and softer stool. This is more forceful than simply adding fibre bulk; therefore cramps and urgency are common adverse effects.
| Group | Examples | Core action |
|---|---|---|
| Anthraquinones | Senna (sennosides), cascara | Colonic stimulation after bacterial activation; increased motility/secretion |
| Diphenylmethanes | Bisacodyl, sodium picosulfate | Direct colonic secretory and motility stimulation |
| Castor oil | Castor oil → ricinoleic acid | Small-intestinal irritant effect with rapid strong peristalsis |
3. Individual drugs
3.1 Senna
Senna contains sennosides, anthraquinone glycosides activated by colonic bacteria. Oral senna is commonly taken at night and often produces a bowel movement in about 8–12 hours. It increases colonic motility and water/electrolyte secretion. It is commonly paired with an osmotic agent or stool softener in a structured bowel regimen, especially for opioid-induced constipation.
- Expected effects: cramps, loose stool, urgency.
- Longer use may cause melanosis coli (a benign pigmentation finding) and reinforces the need to review the cause of chronic constipation.
- Do not label a patient “dependent” merely because they need a stimulant under a long-term opioid or neurogenic-bowel plan; use a documented indication and monitor response.
3.2 Bisacodyl
Bisacodyl is a potent stimulant of the colon. Oral delayed-release tablets commonly act in 6–12 hours; suppositories act faster because they are administered rectally. It is useful for short-term rescue therapy and selected bowel regimens. The supplied lecture correctly notes that bisacodyl acts directly on colonic mucosal nerve fibres.
Enteric-coating rule: swallow bisacodyl delayed-release tablets whole. Do not crush or chew. Do not take within 1 hour of milk or an antacid; premature dissolution in the stomach can cause irritation and pain. The same principle applies when medicines substantially raise gastric pH, so check timing with acid suppressants and current product information.
3.3 Sodium picosulfate
Sodium picosulfate is a diphenylmethane prodrug activated by colonic bacteria. It stimulates colonic secretion and motility. It may be used for constipation or, in different high-volume/protocol-specific preparations, bowel cleansing. Never confuse a constipation dose with a colonoscopy-preparation regimen.
3.4 Castor oil
Castor oil is hydrolysed in the small intestine to ricinoleic acid, which irritates the intestinal mucosa and produces rapid peristalsis. It is generally not preferred for routine constipation because of cramping, diarrhoea and dehydration risk. It can stimulate uterine contraction and should be avoided in pregnancy unless used under specialist obstetric direction.
4. When stimulant laxatives are appropriate
- Short-term constipation when first measures are inadequate and obstruction has been excluded.
- Rescue treatment for a patient with no bowel movement despite an appropriate maintenance regimen.
- Opioid-induced constipation, usually as part of a planned bowel regimen rather than intermittent uncontrolled self-treatment.
- Selected bowel-preparation protocols, using the exact institutional product/regimen.
- Neurogenic bowel or palliative-care bowel plans, under individualised guidance.
5. When they are not appropriate
- Suspected bowel obstruction, perforation, acute inflammatory/surgical abdomen or undiagnosed severe pain/vomiting.
- Uninvestigated rectal bleeding, major weight loss, anaemia or a new persistent change in bowel habit.
- Routine castor-oil self-treatment in pregnancy.
- Repeated escalation for “constipation” without reviewing opioids, impaction, fibre/fluid tolerance and pathology.
6. Adverse effects and complications
| Effect | Why it occurs | Action |
|---|---|---|
| Cramping, urgency, diarrhoea | Increased colonic motility/secretion | Reduce/hold and reassess dose/indication |
| Dehydration, dizziness, weakness | Excess stool water loss | Assess fluid status; urgent review if severe |
| Electrolyte disturbance | Prolonged/excessive diarrhoea, multiple laxatives | Check clinically; correct cause and avoid ongoing misuse |
| Rectal irritation | Rectal formulations/frequent diarrhoea | Review route and local injury |
| Dependency/atonic-colon concern | Often reflects unresolved underlying problem or misuse; evidence should not be oversimplified | Review chronic indication rather than abruptly stopping a necessary supervised regimen |
7. Practical prescribing and counselling
- State the indication and desired stool target: soft, formed, comfortable bowel motions.
- Choose route/onset: oral bedtime dosing may suit next-morning relief; rectal bisacodyl works faster when clinically suitable.
- Use the smallest effective dose and review frequently.
- Drink appropriate fluid unless restricted for cardiac/renal reasons.
- Swallow enteric-coated bisacodyl whole; avoid milk/antacid within one hour.
- Stop and seek review for rectal bleeding, no bowel movement after use, severe pain, vomiting, marked dizziness/weakness or need for repeated continuous self-treatment.
8. Special situations
Opioid-induced constipation
Prevention should begin when long-term opioid therapy starts. A stimulant such as senna, often combined with an osmotic agent according to local protocol, can be appropriate. Bulk fibre alone may be poorly tolerated if motility is markedly reduced. Escalate to targeted agents/specialist review when standard therapy fails.
Pregnancy
Start with diagnosis, diet/routine and better-established options. Senna may occasionally be used under advice, but stimulants should generally be short-term. Bisacodyl needs clinician advice in pregnancy. Avoid castor oil as a home remedy because it can cause severe cramps, diarrhoea, dehydration and uterine activity.
Older or frail adults
Look for impaction, dehydration, immobility, medicines and underlying disease. Start low, monitor fluid status and avoid a cycle of repeated stimulant rescue without an underlying plan.
9. Cases
Case 1: opioid bowel regimen
A patient starts morphine for cancer pain. A bowel regimen is planned from day one. Senna may be appropriate as part of the regimen, with review of stool pattern and escalation if ineffective—do not wait for severe impaction.
Case 2: bisacodyl with milk
A student swallows an enteric-coated bisacodyl tablet with milk and develops epigastric irritation. Explain premature coating dissolution; future tablets must be swallowed whole and not taken near milk/antacid.
Case 3: castor oil in pregnancy
A pregnant patient asks for castor oil because of internet advice. Do not recommend it for self-treatment. Assess constipation and use pregnancy-appropriate management under obstetric guidance.
10. High-yield recall
- Stimulants increase colonic motility plus water/electrolyte secretion.
- Senna: anthraquinone; often 8–12 h; useful in opioid bowel regimens.
- Bisacodyl: direct colonic stimulant; oral delayed-release 6–12 h; suppository faster.
- Do not crush/chew enteric-coated bisacodyl or take near milk/antacid.
- Castor oil: ricinoleic acid, strong irritant effect; avoid routine use and avoid in pregnancy.
- Severe pain, vomiting, distension, bleeding or no flatus means assess—not laxatives.
Sources for further study
- Supplied lecture: Laxatives (1) (SlideShare).
- DailyMed: Bisacodyl delayed-release product information.
- NICE CKS: Choice of laxatives.
